Key facts
- Peptris’s last known valuation is $4.6M (Dec 2023).
- It has raised $9.0M; the latest was Later Stage VC ($7.7M) in Feb 2026.
- Notable investors include Indian Angel Network, Tenacity Ventures, BYT Capital, IITStartups, MeitY Startup Hub — 8 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 8 names
- ·Watchlist + deal alerts for Peptris
- ·The full record, as it builds
Funding rounds
No funding rounds for Peptris are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Peptris
Developer of a drug-discovery platform designed to improve the efficiency of identifying therapeutic compounds. The company's platform uses artificial intelligence and generative models to create optimized molecular structures and reduce reliance on laboratory experiments, enabling pharmaceutical organizations to accelerate research while lowering costs.
- Sector
- Healthcare
- HQ
- Bangalore, India
- Founded
- 2019
- Employees
- 10
- Website
- peptris.com/
- Ownership
- Privately Held (backing)
Peptris doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Peptris shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Peptris in its N-PORT filings yet. We sweep new filings monthly.